Drug intelligence / Profile preview

octane-1,3,5,7-tetracarboxylic acid

Development stage: Unknown
Modality: Small Molecules

Overview

Octane-1,3,5,7-tetracarboxylic acid is a small molecule with the molecular formula C12H18O8. It is an experimental compound and not approved for any medical use. There are no known clinical indications or established mechanisms of action for this substance in drug development or therapy[2][3]. The compound has been cataloged in chemical databases but lacks detailed pharmacological data or therapeutic applications[2][3].

Other names: OCTANE-1,3,5,7-TETRACARBOXYLIC ACID

Targets

CPA1 (Carboxypeptidase A1)Sucrase-Isomaltase

Beyond the preview

Go deeper on octane-1,3,5,7-tetracarboxylic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on octane-1,3,5,7-tetracarboxylic acid.

Explore the full profile